Supha Pharmachem share news, announcements and annual reports
BSE: 539561Commercial Services & SuppliesSmall Cap
SUPHA PHARMACHEM LIMITED · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jan 2016
Last close ₹0.23down ₹0.01 (4.17%)
Share price at the BSE close on 30 Oct 2026. Previous close ₹0.24.
30 Oct: open ₹0.24, high ₹0.24, low ₹0.23
52-week range of traded prices to 30 Oct 2026
₹0.23Low, 22 Oct 2026₹1.66High, 4 Nov 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹20 Cr3,473rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- No recent results
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- No recent results
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 7,94,880
Supha Pharmachem board meetings
151 filed, newest first. Page 1 of 4.
Mar 2026
9 Mar · Board meeting
Meeting on 30 Mar 2026: quarterly results
Feb 2026
25 Feb · Board meeting
Meeting on 9 Mar 2026: quarterly resultsNot held on this date
3 Feb · Board meeting
Meeting on 14 Feb 2026: quarterly results
Nov 2025
6 Nov · Board meeting
Meeting on 14 Nov 2025: quarterly results
Oct 2025
Sep 2025
16 Sep · Board meeting
Meeting on 22 Sep 2025: increase in authorised capital and rights issue
Jul 2025
30 Jul · Board meeting
Meeting on 4 Aug 2025: quarterly results
May 2025
27 May · Board meeting
Meeting on 30 May 2025: audited results
Apr 2025
17 Apr · Board meeting
Meeting on 24 Apr 2025: rights issue of equity shares1 Apr · Board meeting
Meeting on 7 Apr 2025: rights issue
Feb 2025
10 Feb · Board meeting
Meeting on 14 Feb 2025: quarterly results
Jan 2025
17 Jan · Board meeting
Meeting on 22 Jan 2025: rights issue of equity shares and increase in authorised capital
Nov 2024
11 Nov · Board meeting
Meeting on 14 Nov 2024: quarterly results
Oct 2024
31 Oct · Board meeting
Meeting on 31 Oct 2024
Sep 2024
4 Sep · Board meeting
Aug 2024
27 Aug · Board meeting
Meeting on 4 Sep 202414 Aug · Board meeting
Jul 2024
18 Jul · Board meeting
Meeting on 20 Jul 2024: increase in authorised capital15 Jul · Board meeting
Meeting on 14 Aug 2024: quarterly results2 Jul · Board meeting
Meeting on 8 Jul 2024
May 2024